Ingmar HOERR

Person

Tubingen, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Composition for treating prostate cancer (PCa)
- Patent number 12,048,738
- Issue date Jul 30, 2024
- CureVac SE
- Jochen Probst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RNA encoding an antibody
- Patent number 11,596,699
- Issue date Mar 7, 2023
- CureVac SE
- Mariola Fotin-Mleczek
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
RNA-coded antibody
- Patent number 11,421,038
- Issue date Aug 23, 2022
- CureVac AG
- Ingmar Hoerr
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Pharmaceutical composition containing a stabilised mRNA optimised f...
- Patent number 11,369,691
- Issue date Jun 28, 2022
- CureVac AG
- Florian Von Der Mülbe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Pharmaceutical composition containing a stabilised mRNA optimised f...
- Patent number 11,135,312
- Issue date Oct 5, 2021
- CureVac AG
- Florian Von Der Mülbe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
RNA encoding a therapeutic protein
- Patent number 11,078,247
- Issue date Aug 3, 2021
- CureVac AG
- Mariola Fotin-Mleczek
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutical composition containing a stabilised mRNA optimised f...
- Patent number 10,568,972
- Issue date Feb 25, 2020
- CureVac AG
- Florian Von Der Mülbe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acid comprising GlXmGn as an immune-stimulating agent/adjuvant
- Patent number 10,441,653
- Issue date Oct 15, 2019
- CureVac AG
- Ingmar Hoerr
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Composition for treating prostate cancer (PCa)
- Patent number 10,434,154
- Issue date Oct 8, 2019
- CureVac AG
- Jochen Probst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical composition containing a stabilised mRNA optimised f...
- Patent number 10,188,748
- Issue date Jan 29, 2019
- CureVac AG
- Florian Von Der Mülbe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Application of mRNA for use as a therapeutic against tumour diseases
- Patent number 9,655,955
- Issue date May 23, 2017
- CureVac AG
- Ingmar Hoerr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Application of mRNA for use as a therapeutic against tumour diseases
- Patent number 9,463,228
- Issue date Oct 11, 2016
- CureVac AG
- Ingmar Hoerr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Application of mRNA for use as a therapeutic against tumour diseases
- Patent number 9,439,956
- Issue date Sep 13, 2016
- CureVac AG
- Ingmar Hoerr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Application of mRNA for use as a therapeutic against tumour diseases
- Patent number 9,433,670
- Issue date Sep 6, 2016
- CureVac AG
- Ingmar Hoerr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Application of mRNA for use as a therapeutic against tumor diseases
- Patent number 9,433,669
- Issue date Sep 6, 2016
- CureVac AG
- Ingmar Hoerr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Composition for treating prostate cancer (PCa)
- Patent number 9,402,887
- Issue date Aug 2, 2016
- CureVac AG
- Jochen Probst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Composition for treating lung cancer, particularly of non-small lun...
- Patent number 9,352,028
- Issue date May 31, 2016
- CureVac AG
- Marijke Barner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids comprising formula (NuGlXmGnNv)a and derivatives ther...
- Patent number 9,226,959
- Issue date Jan 5, 2016
- CureVac AG
- Thomas Kramps
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Application of mRNA for use as a therapeutic against tumour diseases
- Patent number 9,155,788
- Issue date Oct 13, 2015
- CUREVAC GmbH
- Ingmar Hoerr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Application of mRNA for use as a therapeutic agent for tumorous dis...
- Patent number 8,217,016
- Issue date Jul 10, 2012
- CUREVAC GmbH
- Ingmar Hoerr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TARGETS FOR RNA THERAPEUTICS
- Publication number 20240285795
- Publication date Aug 29, 2024
- CureVac SE
- Ingmar HOERR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNA ENCODING A TUMOR ANTIGEN
- Publication number 20240075116
- Publication date Mar 7, 2024
- CureVac SE
- Mariola FOTIN-MLECZEK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNA ENCODING AN ANTIBODY
- Publication number 20230293731
- Publication date Sep 21, 2023
- CureVac SE
- Mariola FOTIN-MLECZEK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED F...
- Publication number 20230181765
- Publication date Jun 15, 2023
- CureVac SE
- Florian VON DER MÜLBE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THER...
- Publication number 20220401555
- Publication date Dec 22, 2022
- CureVac AG
- Thomas KRAMPS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNA-CODED ANTIBODY
- Publication number 20220372158
- Publication date Nov 24, 2022
- CureVac AG
- Ingmar HOERR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUN...
- Publication number 20220096616
- Publication date Mar 31, 2022
- CureVac AG
- Marijke BARNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNA ENCODING A THERAPEUTIC PROTEIN
- Publication number 20220025369
- Publication date Jan 27, 2022
- CureVac AG
- Mariola FOTIN-MLECZEK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INJECTION SOLUTION FOR RNA
- Publication number 20210308238
- Publication date Oct 7, 2021
- CureVac AG
- Ingmar HOERR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THER...
- Publication number 20200085942
- Publication date Mar 19, 2020
- CureVac AG
- Thomas KRAMPS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNA ENCODING AN ANTIBODY
- Publication number 20200023076
- Publication date Jan 23, 2020
- CureVac AG
- Mariola FOTIN-MLECZEK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NUCLEIC ACID OF FORMULA (I): GlXmGn, OR (II): ClXmCn, IN PARTICULAR...
- Publication number 20200016264
- Publication date Jan 16, 2020
- CureVac AG
- Ingmar HOERR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITION FOR TREATING PROSTATE CANCER (PCa)
- Publication number 20190365879
- Publication date Dec 5, 2019
- CureVac AG
- Jochen PROBST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNA ENCODING A TUMOR ANTIGEN
- Publication number 20190343942
- Publication date Nov 14, 2019
- CureVac AG
- Mariola FOTIN-MLECZEK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNA-CODED ANTIBODY
- Publication number 20190284260
- Publication date Sep 19, 2019
- CureVac AG
- Ingmar HOERR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNA ENCODING A THERAPEUTIC PROTEIN
- Publication number 20190241633
- Publication date Aug 8, 2019
- CureVac AG
- Mariola FOTIN-MLECZEK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED F...
- Publication number 20190134222
- Publication date May 9, 2019
- CureVac AG
- Florian VON DER MÜLBE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUN...
- Publication number 20180256694
- Publication date Sep 13, 2018
- CureVac AG
- Marijke BARNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INJECTION SOLUTION FOR RNA
- Publication number 20180214523
- Publication date Aug 2, 2018
- CureVac AG
- Ingmar HOERR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEW TARGETS FOR RNA THERAPEUTICS
- Publication number 20180126003
- Publication date May 10, 2018
- CureVac AG
- Ingmar HOERR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOSTIMULATION BY CHEMICALLY MODIFIED RNA
- Publication number 20170211068
- Publication date Jul 27, 2017
- CureVac AG
- Ingmar HOERR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPY FOR IMMUNOSTIMULATION
- Publication number 20170000870
- Publication date Jan 5, 2017
- CureVac AG
- Ingmar HOERR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITION FOR TREATING PROSTATE CANCER (PCa)
- Publication number 20170000871
- Publication date Jan 5, 2017
- CureVac AG
- Jochen PROBST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED F...
- Publication number 20160361438
- Publication date Dec 15, 2016
- CureVac AG
- Florian Von Der Mülbe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUN...
- Publication number 20160346370
- Publication date Dec 1, 2016
- CureVac AG
- Marijke BARNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUN...
- Publication number 20160317636
- Publication date Nov 3, 2016
- CureVac AG
- Marijke BARNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITION FOR TREATING PROSTATE CANCER (PCa)
- Publication number 20160303210
- Publication date Oct 20, 2016
- CureVac AG
- Jochen PROBST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THER...
- Publication number 20160250321
- Publication date Sep 1, 2016
- CureVac AG
- Thomas KRAMPS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNA-CODED ANTIBODY
- Publication number 20160185840
- Publication date Jun 30, 2016
- CureVac AG
- Ingmar Hoerr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNA-CODED ANTIBODY
- Publication number 20160166692
- Publication date Jun 16, 2016
- CureVac AG
- Ingmar HOERR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Ingmar HOERR

Person

Patents Grantslast 30 patents

Composition for treating prostate cancer (PCa)

RNA encoding an antibody

RNA-coded antibody

Pharmaceutical composition containing a stabilised mRNA optimised f...

Pharmaceutical composition containing a stabilised mRNA optimised f...

RNA encoding a therapeutic protein

Pharmaceutical composition containing a stabilised mRNA optimised f...

Nucleic acid comprising GlXmGn as an immune-stimulating agent/adjuvant

Composition for treating prostate cancer (PCa)

Pharmaceutical composition containing a stabilised mRNA optimised f...

Application of mRNA for use as a therapeutic against tumour diseases

Application of mRNA for use as a therapeutic against tumour diseases

Application of mRNA for use as a therapeutic against tumour diseases

Application of mRNA for use as a therapeutic against tumour diseases

Application of mRNA for use as a therapeutic against tumor diseases

Composition for treating prostate cancer (PCa)

Composition for treating lung cancer, particularly of non-small lun...

Nucleic acids comprising formula (NuGlXmGnNv)a and derivatives ther...

Application of mRNA for use as a therapeutic against tumour diseases

Application of mRNA for use as a therapeutic agent for tumorous dis...

Patents Applicationslast 30 patents

TARGETS FOR RNA THERAPEUTICS

RNA ENCODING A TUMOR ANTIGEN

RNA ENCODING AN ANTIBODY

PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED F...

NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THER...

RNA-CODED ANTIBODY

COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUN...

RNA ENCODING A THERAPEUTIC PROTEIN

INJECTION SOLUTION FOR RNA

NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THER...

RNA ENCODING AN ANTIBODY

NUCLEIC ACID OF FORMULA (I): GlXmGn, OR (II): ClXmCn, IN PARTICULAR...

COMPOSITION FOR TREATING PROSTATE CANCER (PCa)

RNA ENCODING A TUMOR ANTIGEN

RNA-CODED ANTIBODY

RNA ENCODING A THERAPEUTIC PROTEIN

PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED F...

COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUN...

INJECTION SOLUTION FOR RNA

NEW TARGETS FOR RNA THERAPEUTICS

IMMUNOSTIMULATION BY CHEMICALLY MODIFIED RNA

COMBINATION THERAPY FOR IMMUNOSTIMULATION

COMPOSITION FOR TREATING PROSTATE CANCER (PCa)

PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED F...

COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUN...

COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUN...

COMPOSITION FOR TREATING PROSTATE CANCER (PCa)

NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THER...

RNA-CODED ANTIBODY

RNA-CODED ANTIBODY